BAXJECT III offers one-step activation for reconstituting1

BAXJECT III Reconstitution System

Easy one-step activation for reconstituting with ADYNOVATE1

  • Eliminates the need to disinfect individual vials, as vials are already assembled in the system housing
    • Always ensure you work on a clean surface and wash your hands before reconstituting
  • Straightforward pooling process if more than 1 vial is needed—all ADYNOVATE can be drawn into the same syringe

For detailed step-by-step instructions for reconstituting ADYNOVATE with BAXJECT III Reconstitution System, watch the video below or download the instructions for use.

BAXJECT III reconstitution demo video (length: 5:58)

Infusion information for ADYNOVATE

Patients should be trained on how to self-infuse by their healthcare provider or hemophilia treatment center. ADYNOVATE can be administered via continuous infusion, bolus infusion, or through a combination of both methods.1

ADYNOVATE prophylaxis indicated dose1

  • Children (< 12 years): 55 IU/kg twice weekly, with a maximum of 70 IU/kg
  • Adolescents and adults (12 years and older): 40-50 IU/kg twice weekly

Adjust the dose based on the patient's clinical response.

SELECTED IMPORTANT RISK INFORMATION

WARNINGS & PRECAUTIONS

Hypersensitivity Reactions: Hypersensitivity reactions are possible with ADYNOVATE. Allergic-type hypersensitivity reactions, including anaphylaxis, have been reported with other recombinant antihemophilic factor VIII products, including the parent molecule, ADVATE. Early signs of hypersensitivity reactions that can progress to anaphylaxis may include angioedema, chest tightness, dyspnea, wheezing, urticaria, and pruritus. Immediately discontinue administration and initiate appropriate treatment if hypersensitivity reactions occur.
See Detailed Important Risk Information below.

Having trouble with the
BAXJECT III Reconstitution system?

Learn how to recover ADYNOVATE if the initial reconstitution procedure fails in the video below.

BAXJECT III reconstitution troubleshooting video (length: 6:34)

How to store and handle ADYNOVATE1

  • Store ADYNOVATE in powder form at 2° to 8°C (36° to 46°F)
  • Do not freeze
  • ADYNOVATE may be stored at room temperature not to exceed 30°C (86°F) for a period of up to 3 months not to exceed the expiration date
  • After storage at room temperature, do not return the product to the refrigerator
  • Do not use beyond expiration date printed on the carton or vial
  • Store vials in their original box and protect from extreme light exposure
  • After reconstitution, do not refrigerate the solution. Use the reconstituted solution immediately or within 3 hours after reconstitution. Discard any remaining solution
Access myPKFiT

Learn how you and your patients can get started using the myPKFiT app

Get started
Request a representative

Request a local representative to answer your questions about Takeda products and programs

Request Now